LONDON, Feb. 27, 2018 /PRNewswire/ -- The global defibrillators market projected to grow at a CAGR of 3.1%.
The global defibrillators market is expected to reach USD 10.88 billion by 2022 from USD 9.32 billion in 2017, growing at a CAGR of 3.1%. Factors such as technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market.
Download the full report: https://www.reportbuyer.com/product/4141096
However, issues related to the use of implantable and automated external defibrillators are expected to restrain the growth of the defibrillators market in the forecast period.
The defibrillators market has witnessed significant developments in terms of technological advancements and new product developments. The external defibrillators available in the market have provided numerous benefits to patients in terms of ease-of-use, increased patient comfort, and increased accessibility.
The external defibrillators segment is expected to grow at the highest CAGR during 2017 to 2022.
On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs).
The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).
The external defibrillators segment is expected to grow at the highest CAGR in the forecast period, owing to factors such as the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.
The hospitals, clinics, and cardiac centers segment to dominate the global defibrillators market during the forecast period.
On the basis of end user, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The hospitals, clinics, and cardiac centers segment is estimated to account for the largest share of the defibrillators market in 2017. Growing number of cardiac implant procedures across the globe and the availability of reimbursements across the developed markets are some of the major factors driving the growth of this segment.
APAC is projected to witness the highest growth during the forecast period.
The Asia Pacific defibrillators market is expected to grow at the highest CAGR of from 2017 to 2022. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific defibrillators market.
Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type - Tier 1 –31%, Tier 2 –48% and Tier 3 –21%
• By Designation – C-level – 26%, Director-level – 24%, Others – 50%
• By Region – North America – 29%, Europe – 35%, APAC – 21%, RoW – 15%
The key players in the defibrillators market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Koninklijke Philips N.V. (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).
Research Coverage
This report studies the defibrillators market based on product, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.
It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on business strategies adopted by the major players in the defibrillators market. The report analyzes the defibrillators market based on product, end user, and region
• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the defibrillators market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various defibrillators across geographies
• Market Diversification: Exhaustive information about new defibrillator products, untapped geographies, recent developments, and investments in the defibrillators market
• Competitive Assessment: In-depth assessment of market ranking, strategies, and products of leading players in the defibrillators market
Download the full report: https://www.reportbuyer.com/product/4141096
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/the-global-defibrillators-market-projected-to-grow-at-a-cagr-of-31-300605214.html
Share this article